TR199500981A2 - Laktamlar, bilhassa azetidinilalkillaktam türevleri. - Google Patents

Laktamlar, bilhassa azetidinilalkillaktam türevleri.

Info

Publication number: TR199500981A2
Authority: TR; Turkey
Prior art keywords: alkyl; cycloalkyl; fluoro; aryl; pct
Prior art date: 1994-08-09

Application number

TR95/00981A

Other languages

English (en)

Inventor

Alan Patrick Marchington

Alexander Roderick Mackenzie

Sandra Dora Meadows

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-09

Filing date

1995-08-09

Publication date

1996-06-21

1994-08-09 Priority claimed from GB9416084A external-priority patent/GB9416084D0/en

1995-08-09 Application filed by Pfizer filed Critical Pfizer

1996-06-21 Publication of TR199500981A2 publication Critical patent/TR199500981A2/tr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Hydrogenated Pyridines (AREA)
Liquid Crystal (AREA)

TR95/00981A 1994-08-09 1995-08-09 Laktamlar, bilhassa azetidinilalkillaktam türevleri. TR199500981A2 (tr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB9416084A GB9416084D0 (en)	1994-08-09	1994-08-09	Lactams
GB9417898A GB9417898D0 (en)	1994-08-09	1994-09-06	Lactams

Publications (1)

Publication Number	Publication Date
TR199500981A2 true TR199500981A2 (tr)	1996-06-21

Family

ID=26305431

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TR95/00981A TR199500981A2 (tr)	1994-08-09	1995-08-09	Laktamlar, bilhassa azetidinilalkillaktam türevleri.

Country Status (24)

Country	Link
US (1)	US5968923A (tr)
EP (1)	EP0775132B1 (tr)
JP (1)	JP3159389B2 (tr)
CN (1)	CN1072666C (tr)
AT (1)	ATE200083T1 (tr)
AU (1)	AU689303B2 (tr)
BR (1)	BR9503582A (tr)
CA (1)	CA2197086C (tr)
CZ (1)	CZ291544B6 (tr)
DE (1)	DE69520502T2 (tr)
DK (1)	DK0775132T3 (tr)
ES (1)	ES2155894T3 (tr)
FI (1)	FI970523A0 (tr)
GR (1)	GR3035726T3 (tr)
HU (1)	HUT77771A (tr)
IL (1)	IL114826A (tr)
MY (1)	MY115975A (tr)
NO (1)	NO311977B1 (tr)
NZ (1)	NZ291423A (tr)
PT (1)	PT775132E (tr)
RU (1)	RU2150468C1 (tr)
TR (1)	TR199500981A2 (tr)
TW (1)	TW432061B (tr)
WO (1)	WO1996005193A1 (tr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9524157D0 (en) *	1995-11-25	1996-01-24	Pfizer Ltd	Therapeutic agents
GB9600235D0 (en) *	1996-01-05	1996-03-06	Pfizer Ltd	Therapeutic agents
GB9601202D0 (en) *	1996-01-22	1996-03-20	Pfizer Ltd	Piperidones
GB9601680D0 (en) *	1996-01-27	1996-03-27	Pfizer Ltd	Therapeutic agents
GB9601697D0 (en) *	1996-01-27	1996-03-27	Pfizer Ltd	Therapeutic agents
GB9714129D0 (en) *	1997-07-04	1997-09-10	Pfizer Ltd	Azetidines
WO1999019297A1 (en) *	1997-10-15	1999-04-22	Coelacanth Chemical Corporation	Synthesis of azetidine derivatives
NZ504848A (en) *	1997-12-04	2002-10-25	Sankyo Co	Piperidine alkylene substituted morpholino derivatives
GB9812037D0 (en) *	1998-06-04	1998-07-29	Pfizer Ltd	Piperidones
WO2000063168A1 (en) *	1999-04-16	2000-10-26	Coelacanth Chemical Corporation	Synthesis of azetidine derivatives
EP1299100B1 (en) *	2000-06-12	2007-07-25	The University Of Rochester	Method of treating hot flashes, using tachykinin receptor antagonist
GB0130261D0 (en)	2001-12-18	2002-02-06	Pfizer Ltd	Lactams as tachykinin antagonists
CA2472715A1 (en)	2002-01-18	2003-07-31	Merck & Co., Inc.	Edg receptor agonists
TW200508221A (en)	2003-06-13	2005-03-01	Astrazeneca Ab	New azetidine compounds
US7511159B2 (en)	2003-12-25	2009-03-31	Ono Pharmaceutical Co., Ltd.	Azetidine ring compounds and drugs comprising the same
WO2006020049A2 (en)	2004-07-15	2006-02-23	Amr Technology, Inc.	Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ATE550019T1 (de)	2005-05-17	2012-04-15	Merck Sharp & Dohme	Cis-4-ä(4-chlorophenyl)sulfonylü-4-(2,5- difluorophenyl)cyclohexanepropansäure zur behandlug von krebs
KR101589551B1 (ko)	2005-07-15	2016-02-02	알바니 몰레큘라 리써치, 인크.	아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도
CN101277960A (zh)	2005-09-29	2008-10-01	默克公司	作为黑皮质素-4受体调节剂的酰化螺哌啶衍生物
AR057828A1 (es)	2005-09-29	2007-12-19	Astrazeneca Ab	Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica
GB0603041D0 (en)	2006-02-15	2006-03-29	Angeletti P Ist Richerche Bio	Therapeutic compounds
US8106208B2 (en)	2006-05-18	2012-01-31	Albireo Ab	Benzamide compounds that act as NK receptor antagonists
US8173629B2 (en)	2006-09-22	2012-05-08	Merck Sharp & Dohme Corp.	Method of treatment using fatty acid synthesis inhibitors
US20110218176A1 (en)	2006-11-01	2011-09-08	Barbara Brooke Jennings-Spring	Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
CN101190330A (zh)	2006-11-30	2008-06-04	深圳市鼎兴生物医药技术开发有限公司	胆碱酯酶在拮抗速激肽药物中的应用
WO2008076042A1 (en) *	2006-12-19	2008-06-26	Astrazeneca Ab	Azetidinpiperazine derivatives that are neurokinin (nk) receptor antagonists and their use.
RS58936B1 (sr)	2007-01-10	2019-08-30	Msd Italia Srl	Indazoli supstituisani amidom kao inhibitori poli(adp-riboza)polimeraze (parp)
EP2145884B1 (en)	2007-04-02	2014-08-06	Msd K.K.	Indoledione derivative
US8389553B2 (en)	2007-06-27	2013-03-05	Merck Sharp & Dohme Corp.	4-carboxybenzylamino derivatives as histone deacetylase inhibitors
US8598184B2 (en)	2008-03-03	2013-12-03	Tiger Pharmatech	Protein kinase inhibitors
US9156812B2 (en)	2008-06-04	2015-10-13	Bristol-Myers Squibb Company	Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
DE102008063992A1 (de)	2008-12-19	2010-09-02	Lerner, Zinoviy, Dipl.-Ing.	Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung
US8691825B2 (en)	2009-04-01	2014-04-08	Merck Sharp & Dohme Corp.	Inhibitors of AKT activity
EP2429293B1 (en)	2009-05-12	2014-10-29	Bristol-Myers Squibb Company	CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
CA2760837C (en)	2009-05-12	2018-04-03	Albany Molecular Research, Inc.	7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
KR20120034644A (ko)	2009-05-12	2012-04-12	알바니 몰레큘라 리써치, 인크.	아릴, 헤테로아릴, 및 헤테로사이클 치환된 테트라하이드로이소퀴놀린 및 이의 용도
US8399451B2 (en)	2009-08-07	2013-03-19	Bristol-Myers Squibb Company	Heterocyclic compounds
CN104945382B (zh)	2009-10-14	2020-02-07	默沙东公司	提高p53活性的取代的哌啶和其用途
WO2011163330A1 (en)	2010-06-24	2011-12-29	Merck Sharp & Dohme Corp.	Novel heterocyclic compounds as erk inhibitors
US8946434B2 (en)	2010-07-16	2015-02-03	N30 Pharmaceuticals, Inc.	Dihydropyridin-2(1H)-one compound as S-nirtosoglutathione reductase inhibitors and neurokinin-3 receptor antagonists
WO2012018754A2 (en)	2010-08-02	2012-02-09	Merck Sharp & Dohme Corp.	RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
US9029341B2 (en)	2010-08-17	2015-05-12	Sirna Therapeutics, Inc.	RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)
EP2608669B1 (en)	2010-08-23	2016-06-22	Merck Sharp & Dohme Corp.	NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
EP2613782B1 (en)	2010-09-01	2016-11-02	Merck Sharp & Dohme Corp.	Indazole derivatives useful as erk inhibitors
US9242981B2 (en)	2010-09-16	2016-01-26	Merck Sharp & Dohme Corp.	Fused pyrazole derivatives as novel ERK inhibitors
US9260471B2 (en)	2010-10-29	2016-02-16	Sirna Therapeutics, Inc.	RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)
WO2012087772A1 (en)	2010-12-21	2012-06-28	Schering Corporation	Indazole derivatives useful as erk inhibitors
US20140045847A1 (en)	2011-04-21	2014-02-13	Piramal Enterprises Limited	Crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation
CN102321045B (zh) *	2011-06-13	2013-07-17	陕西瑞科新材料股份有限公司	一种制备高吗啉盐酸盐的方法
EP2770987B1 (en)	2011-10-27	2018-04-04	Merck Sharp & Dohme Corp.	Novel compounds that are erk inhibitors
EP3453762B1 (en)	2012-05-02	2021-04-21	Sirna Therapeutics, Inc.	Short interfering nucleic acid (sina) compositions
MX2015004041A (es)	2012-09-28	2015-07-06	Merck Sharp & Dohme	Compuestos novedosos que son inhibidores de erk.
WO2014085216A1 (en)	2012-11-28	2014-06-05	Merck Sharp & Dohme Corp.	Compositions and methods for treating cancer
CA2895504A1 (en)	2012-12-20	2014-06-26	Merck Sharp & Dohme Corp.	Substituted imidazopyridines as hdm2 inhibitors
EP2951180B1 (en)	2013-01-30	2018-05-02	Merck Sharp & Dohme Corp.	2,6,7,8 substituted purines as hdm2 inhibitors
EP3041938A1 (en)	2013-09-03	2016-07-13	Moderna Therapeutics, Inc.	Circular polynucleotides
CN107176917A (zh) *	2017-05-11	2017-09-19	蚌埠中实化学技术有限公司	一种制备二甲胺基磺酰氯的方法
WO2019094311A1 (en)	2017-11-08	2019-05-16	Merck Sharp & Dohme Corp.	Prmt5 inhibitors
US11981701B2 (en)	2018-08-07	2024-05-14	Merck Sharp & Dohme Llc	PRMT5 inhibitors
EP3833668A4 (en)	2018-08-07	2022-05-11	Merck Sharp & Dohme Corp.	PRMT5 INHIBITORS

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2663329B1 (fr) *	1990-06-15	1992-10-16	Sanofi Sa	Composes aromatiques amines, procede pour leur preparation et compositions pharmaceutiques les contenant.
IL99320A (en) *	1990-09-05	1995-07-31	Sanofi Sa	Arylalkylamines, their preparation and pharmaceutical preparations containing them
FR2676054B1 (fr) *	1991-05-03	1993-09-03	Sanofi Elf	Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2676055B1 (fr) *	1991-05-03	1993-09-03	Sanofi Elf	Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
CA2106840A1 (en) *	1992-09-25	1994-03-26	Marco Baroni	Heteroarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them
GB9321557D0 (en) *	1992-11-03	1993-12-08	Zeneca Ltd	Carboxamide derivatives
DK0681571T3 (da) *	1993-01-28	1998-11-23	Merck & Co Inc	Spiro-substituerede azacykliske forbindelser som tachykininreceptorantagonister
GB9305718D0 (en) *	1993-03-19	1993-05-05	Glaxo Group Ltd	Medicaments
FR2703679B1 (fr) *	1993-04-05	1995-06-23	Rhone Poulenc Rorer Sa	Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
GB9310066D0 (en) *	1993-05-17	1993-06-30	Zeneca Ltd	Alkyl substituted heterocycles
GB9310713D0 (en) *	1993-05-24	1993-07-07	Zeneca Ltd	Aryl substituted heterocycles
JPH08511522A (ja) *	1993-06-07	1996-12-03	メルクエンドカンパニーインコーポレーテッド	ニューロキニンアンタゴニストとしてのスピロ置換アザ環
AU682510B2 (en) *	1993-07-01	1997-10-09	Pfizer Japan Inc.	2-(1-(1,3-thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivatives
GB9317104D0 (en) *	1993-08-17	1993-09-29	Zeneca Ltd	Therapeutic heterocycles
GB9322643D0 (en) *	1993-11-03	1993-12-22	Zeneca Ltd	Lactam derivatives
US5472958A (en) *	1994-08-29	1995-12-05	Abbott Laboratories	2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function

1995
- 1995-07-17 TW TW084107375A patent/TW432061B/zh not_active IP Right Cessation
- 1995-07-29 AT AT95929036T patent/ATE200083T1/de not_active IP Right Cessation
- 1995-07-29 JP JP50697496A patent/JP3159389B2/ja not_active Expired - Fee Related
- 1995-07-29 DK DK95929036T patent/DK0775132T3/da active
- 1995-07-29 NZ NZ291423A patent/NZ291423A/en unknown
- 1995-07-29 WO PCT/EP1995/003054 patent/WO1996005193A1/en active IP Right Grant
- 1995-07-29 DE DE69520502T patent/DE69520502T2/de not_active Expired - Fee Related
- 1995-07-29 CA CA002197086A patent/CA2197086C/en not_active Expired - Fee Related
- 1995-07-29 HU HU9700373A patent/HUT77771A/hu unknown
- 1995-07-29 RU RU97104032/04A patent/RU2150468C1/ru not_active IP Right Cessation
- 1995-07-29 US US08/798,534 patent/US5968923A/en not_active Expired - Fee Related
- 1995-07-29 CZ CZ1997381A patent/CZ291544B6/cs not_active IP Right Cessation
- 1995-07-29 CN CN95194416A patent/CN1072666C/zh not_active Expired - Fee Related
- 1995-07-29 ES ES95929036T patent/ES2155894T3/es not_active Expired - Lifetime
- 1995-07-29 EP EP95929036A patent/EP0775132B1/en not_active Expired - Lifetime
- 1995-07-29 AU AU32549/95A patent/AU689303B2/en not_active Ceased
- 1995-07-29 PT PT95929036T patent/PT775132E/pt unknown
- 1995-08-02 MY MYPI95002252A patent/MY115975A/en unknown
- 1995-08-03 IL IL11482695A patent/IL114826A/xx not_active IP Right Cessation
- 1995-08-08 BR BR9503582A patent/BR9503582A/pt not_active IP Right Cessation
- 1995-08-09 TR TR95/00981A patent/TR199500981A2/tr unknown
1997
- 1997-02-07 FI FI970523A patent/FI970523A0/fi not_active Application Discontinuation
- 1997-02-07 NO NO19970566A patent/NO311977B1/no unknown
2001
- 2001-04-06 GR GR20010400578T patent/GR3035726T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
CZ38197A3 (cs)	1998-01-14
FI970523A (fi)	1997-02-07
TW432061B (en)	2001-05-01
CA2197086C (en)	2000-07-25
DE69520502T2 (de)	2001-07-12
CN1072666C (zh)	2001-10-10
JPH09508646A (ja)	1997-09-02
EP0775132B1 (en)	2001-03-28
EP0775132A1 (en)	1997-05-28
FI970523A0 (fi)	1997-02-07
NO970566D0 (no)	1997-02-07
GR3035726T3 (en)	2001-07-31
NO311977B1 (no)	2002-02-25
MY115975A (en)	2003-10-31
JP3159389B2 (ja)	2001-04-23
RU2150468C1 (ru)	2000-06-10
IL114826A0 (en)	1995-12-08
MX9701006A (es)	1998-05-31
CA2197086A1 (en)	1996-02-22
ATE200083T1 (de)	2001-04-15
PT775132E (pt)	2001-07-31
CZ291544B6 (cs)	2003-04-16
WO1996005193A1 (en)	1996-02-22
NZ291423A (en)	1998-03-25
AU3254995A (en)	1996-03-07
NO970566L (no)	1997-02-07
ES2155894T3 (es)	2001-06-01
AU689303B2 (en)	1998-03-26
BR9503582A (pt)	1996-04-30
CN1154699A (zh)	1997-07-16
HUT77771A (hu)	1998-08-28
IL114826A (en)	1999-12-31
DE69520502D1 (de)	2001-05-03
DK0775132T3 (da)	2001-04-30
US5968923A (en)	1999-10-19

Publication	Publication Date	Title
TR199500981A2 (tr)	1996-06-21	Laktamlar, bilhassa azetidinilalkillaktam türevleri.
EA200000334A1 (ru)	2000-10-30	Производные карбоксамидотиазолов, их получение, содержащие их фармацевтические композиции
NO954564D0 (no)	1995-11-13	N-acylsulfaminsyre-estere (eller-tioestere), N-acylsulfonamider og N-sulfonyl-karbaminsyre-estere (eller-tioestere) som hypercholesterolemiske midler
DK116480A (da)	1980-09-21	Fremgangsmaade til fremstilling af substituerede chromoner
DE69103481T3 (de)	1998-06-18	Färbemittel, enthaltend 5-6-Dihydroxyindoline und Färbungsverfahren für keratinische Fasern.
DE69231445T2 (de)	2001-01-11	Triazole enthaltende antifungizide mittel
AU5117890A (en)	1990-09-13	Trifluromethylphenylazolylmethyloxiranes, the preparation thereof and the use thereof as crop protection agents
CO4750815A1 (es)	1999-03-31	Acetidinas
MX9307186A (es)	1994-08-31	Composicion tintorea para las fibras queratinicas.
FI943931A (fi)	1994-08-26	Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina
DK1471059T3 (da)	2007-07-16	2,4,6-tris(dineopentyl-4'-aminobenzalmalonat)-s-triazin, fotobeskyttende kosmetiske sammensætninger indeholdende denne forbindelse og anvendelse af den nævnte forbindelse
FI970449A0 (fi)	1997-02-03	N-substituoituja atsabisykloheptaanijohdannaisia, jotka ovat käyttökelpoisia neuroleptisinä aineina
DE69131774T2 (de)	2000-06-21	Antibakterielle penem-ester derivate
ATE203533T1 (de)	2001-08-15	INDOLDERIVATE ALS PRODRUGS VON ß5-HT1-LIKEß REZEPTOR AGONISTEN
ECSP951504A (es)	1996-12-13	Lactamas
ES2157682T3 (es)	2001-08-16	Composiciones para el teñido de las fibras queratinicas que contienen derivados de 3-aminopirazolinas a titulo de copulador, procedimiento de teñido y kit de tinte.
ATE19629T1 (de)	1986-05-15	N-substituierte derivate des tetrahydroisophthalimids.
FI882421A0 (fi)	1988-05-23	5-fenyl-1,2,3a,4,5,9b-hexahydro-3h -benz(e)indol, deras framstaellning och anvoendning som laekemedel.
ES2120885A1 (es)	1998-11-01	Nuevas tienopirimidonas con actividad antifungica.